Viewing Study NCT00586092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2026-04-16 @ 11:38 AM
Study NCT ID: NCT00586092
Status: COMPLETED
Last Update Posted: 2013-04-08
First Post: 2007-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors
Sponsor: Herbert Hurwitz
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None Phase 1 View
None avastin View
None bevacizumab View
None ABT-510 View
None solid tumors View
None angiogenesis View